Literature DB >> 20715116

VEGF stimulates PKD-mediated CREB-dependent orphan nuclear receptor Nurr1 expression: role in VEGF-induced angiogenesis.

Dezheng Zhao1, Sachin Desai, Huiyan Zeng.   

Abstract

New vessel formation is critical for solid tumor growth and it is primarily stimulated by the most potent angiogenic factor vascular endothelial growth factor (VEGF or VEGF-A165). VEGF promotes endothelial cell proliferation by initiating signaling cascades to increase gene transcription. Recent works showed that VEGF potently and rapidly induces expression of orphan nuclear receptor Nurr1 in endothelial cells. However, the signaling pathway for VEGF-induced Nurr1 expression and its role in VEGF-induced endothelial cell proliferation and angiogenic response have not been examined. In our study, we first show that VEGF significantly induces expression of Nurr1 mRNA, protein and its promoter activity in cultured endothelial cells. Furthermore, the promoter analysis shows that deletion of the putative cAMP-responsive element binding protein (CREB) site in the proximal region of the promoter markedly reduces VEGF-induced promoter activity whereas deletion of the upstream NF-κB site has moderate effect. Transfection of a dominant negative CREB mutant (K-CREB) or mutation of this putative CREB site in the Nurr1 promoter attenuates VEGF-induced Nurr1 expression. VEGF also stimulates the binding of nuclear CREB protein to its site in the Nurr1 promoter in vitro and in vivo. Moreover, using pharmacological inhibitors and molecular approaches, we show that VEGF-induced CREB activation is largely mediated by protein kinase C-dependent protein kinase D activation. Finally, our data indicate that knockdown of endogenous Nurr1 expression attenuates VEGF-induced endothelial cell proliferation, migration and in vivo matrigel angiogenesis, suggesting its potential importance in mediating VEGF-induced tumor angiogenesis.
Copyright © 2010 UICC.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20715116     DOI: 10.1002/ijc.25600

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  22 in total

1.  Nuclear receptors Nur77 and Nurr1 modulate mesenchymal stromal cell migration.

Authors:  Marijke W Maijenburg; Christian Gilissen; Sara M Melief; Marion Kleijer; Kees Weijer; Anja Ten Brinke; Helene Roelofs; Claudia M Van Tiel; Joris A Veltman; Carlie J M de Vries; C Ellen van der Schoot; Carlijn Voermans
Journal:  Stem Cells Dev       Date:  2011-06-01       Impact factor: 3.272

Review 2.  Nurr1-Based Therapies for Parkinson's Disease.

Authors:  Jie Dong; Song Li; Jing-Lin Mo; Huai-Bin Cai; Wei-Dong Le
Journal:  CNS Neurosci Ther       Date:  2016-03-25       Impact factor: 5.243

3.  NR4A nuclear receptors in immunity and atherosclerosis.

Authors:  Anouk A J Hamers; Richard N Hanna; Heba Nowyhed; Catherine C Hedrick; Carlie J M de Vries
Journal:  Curr Opin Lipidol       Date:  2013-10       Impact factor: 4.776

4.  AP-1 transcription factor mediates VEGF-induced endothelial cell migration and proliferation.

Authors:  Jing Jia; Taiyang Ye; Pengfei Cui; Qian Hua; Huiyan Zeng; Dezheng Zhao
Journal:  Microvasc Res       Date:  2016-02-06       Impact factor: 3.514

Review 5.  The interplay of NR4A receptors and the oncogene-tumor suppressor networks in cancer.

Authors:  Jordan A Beard; Alexa Tenga; Taosheng Chen
Journal:  Cell Signal       Date:  2014-11-15       Impact factor: 4.315

6.  Clinicopathological significance of orphan nuclear receptor Nurr1 expression in gastric cancer.

Authors:  J Guo; G Zu; T Zhou; J Xing; Z Wang
Journal:  Clin Transl Oncol       Date:  2015-05-29       Impact factor: 3.405

7.  Role of nuclear receptor NR4A2 in gastrointestinal inflammation and cancers.

Authors:  Yi-Fang Han; Guang-Wen Cao
Journal:  World J Gastroenterol       Date:  2012-12-21       Impact factor: 5.742

8.  C19MC microRNAs regulate the migration of human trophoblasts.

Authors:  Lan Xie; Jean-Francois Mouillet; Tianjiao Chu; W Tony Parks; Elena Sadovsky; Martin Knöfler; Yoel Sadovsky
Journal:  Endocrinology       Date:  2014-09-11       Impact factor: 4.736

9.  Theranostic tumor homing nanocarriers for the treatment of lung cancer.

Authors:  Apurva R Patel; Mahavir B Chougule; Ed Lim; Kevin P Francis; Stephen Safe; Mandip Singh
Journal:  Nanomedicine       Date:  2013-12-17       Impact factor: 5.307

10.  Niche-modulated and niche-modulating genes in bone marrow cells.

Authors:  Y Cohen; O Garach-Jehoshua; A Bar-Chaim; A Kornberg
Journal:  Blood Cancer J       Date:  2012-12-14       Impact factor: 11.037

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.